Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may improve metabolic health before conception.
- The impact of GLP-1 RAs on hypertensive disorders of pregnancy (HDP) is not yet established.
- There is a potential link between GLP-1 RAs and improved metabolic health in women planning for pregnancy.
- Further research is needed to clarify the safety of GLP-1 RAs during early pregnancy.
Simplified